IceCure Medical Ltd (ICCM) Company Profile - Business Overview, Management Team & Corporate Information - Stocknear

IceCure Medical Ltd

NASDAQ: ICCM · Real-Time Price · USD
1.03
0.00 (0.00%)
At close: Sep 26, 2025, 3:59 PM
1.04
0.48%
After-hours: Sep 26, 2025, 07:59 PM EDT

Company Description

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body.

It offers ProSense system, a cryoablation solution for the treatment of breast tumors.

The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

IceCure Medical Ltd
IceCure Medical Ltd logo
Country IL
IPO Date Aug 26, 2021
Industry Medical - Devices
Sector Healthcare
Employees 64
CEO Eyal Shamir

Contact Details

Address:
7 Ha’Eshel Street
Caesarea,
IL
Website https://www.icecure-medical.com

Stock Details

Ticker Symbol ICCM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001584371
CUSIP Number M53071136
ISIN Number IL0011224156
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Eyal Shamir Chief Executive Officer & Director
Ronen Tsimerman CPA Chief Financial Officer & Chief Operating Officer
Galit Malik Vice President of Operations & Service
Merav Nir Dotan Vice President of Human Resources
Shad Good Vice President of Sales for North America
Tlalit Bussi Tel-Tzure Vice President of Business Development & Global Marketing

Latest SEC Filings

Date Type Title
Sep 22, 2025 6-K Filing
Sep 19, 2025 POS AM Filing
Sep 18, 2025 6-K Filing
Sep 15, 2025 6-K Filing
Sep 04, 2025 F-3 Filing
Sep 04, 2025 6-K Filing
Sep 04, 2025 6-K Filing
Aug 20, 2025 6-K Filing
Aug 13, 2025 6-K Filing
Aug 01, 2025 6-K/A [Amend] Filing